Zika Virus Net is the web resource for anyone interested in Zika virus. Zika virus (ZIKV) is an insect-borne virus, of the flavivirus genus, that is spread by Aedes mosquitoes. The most common symptoms of Zika virus disease (Zika) are fever, rash, joint pain, and red eye. The illness is usually mild with symptoms lasting from several days to a week. Severe disease requiring hospitalization is uncommon. The symptoms of Zika are similar to those of dengue and chikungunya, which are diseases caused by other viruses spread by the same type of mosquitoes. Zika virus can be spread from a pregnant woman to her unborn baby. There have been reports of a serious birth defect of the brain called microcephaly and other poor pregnancy outcomes in babies of mothers who were infected with Zika virus while pregnant. On February 1st, 2016, the WHO declared the Zika outbreak as a Public Health Emergency of International Concern (PHEIC). As of August 2017 the number of new Zika virus cases in the Americas had fallen dramatically.

The objectives of Zika Virus Net are to be the public and professional information resource for zika fever and to serve as a network in the exchange of information and news related to zika.

• Commonly used antibiotic shows promise for combating Zika infections - National Institutes of Health
  Tue, 24 Nov 2020 17:36 GMT
• Why Zika Never Exploded In Africa: A New Study Offers Clues : Goats and Soda - NPR
  Fri, 20 Nov 2020 08:00 GMT
• Mosquitos in Asia and the Americas More Susceptible to Zika Virus - The Scientist
  Thu, 19 Nov 2020 08:00 GMT
• Mosquito genetics could explain lack of large Zika outbreak in Africa - Healio
  Tue, 24 Nov 2020 18:51 GMT
• Study: Zika virus solution may lie in commonly used, tetracycline-based antibiotics - Homeland Preparedness News
  Mon, 30 Nov 2020 13:17 GMT
• CD8+ T cells mediate protection against Zika virus induced by an NS3-based vaccine - Science Advances
  Wed, 04 Nov 2020 08:00 GMT
• Tetracycline-based Antibiotics Show Promise for Combating Zika Infections - Global Biodefense
  Thu, 26 Nov 2020 00:03 GMT
• Africa’s Mosquitoes Dislike Zika Virus - Zika News
  Sat, 21 Nov 2020 14:15 GMT
• Epilepsy surveillance in normocephalic children with and without prenatal Zika virus exposure - DocWire News
  Mon, 30 Nov 2020 06:00 GMT
• Tetracycline antibiotics show promise against Zika virus - Drug Target Review
  Wed, 25 Nov 2020 12:50 GMT
• Methacycline shows promise for combating Zika infections - Medical Dialogues
  Sat, 28 Nov 2020 08:53 GMT
• Zika Virus Infection Drug Market 2020 Determined By Manufacturing Summary, Business Profile And Estimate To 2026 - The Market Feed
  Tue, 01 Dec 2020 12:35 GMT
• Zika Virus Vaccines Market Size 2020 With Impact Analysis of COVID-19, Emerging Trends, Business Challenges, Merger, Acquisition and New Investment, Future Growth, Revenue, Forecast to 2025 - The Market Feed
  Wed, 02 Dec 2020 07:05 GMT
• Zika Virus Testing Market and Ecosystem Analysis, Competitive Landscape (Latin America, North Amercia, Europe, Asia-Pacific, More) - The Market Feed
  Tue, 01 Dec 2020 01:00 GMT
• SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research - News-Medical.Net
  Wed, 25 Nov 2020 05:15 GMT

• PRO/EDR> Chikungunya (05): Americas, Africa, Asia, research, observations
  Tue, 17 Nov 2020 08:21:43 -0500
  Chikungunya -- Costa Rica
  Summary
  -------
  Background
  Since 2015, the arthropodborne viruses (arboviruses) Zika and chikungunya have spread across the Americas causing outbreaks, accompanied by increases in immune-mediated and infectious neurological disease. The spectrum of neurological manifestations linked to these viruses, and the importance of dual infection, are not known fully. We aimed to investigate whether neurological presentations differed according to the infecting arbovirus and whether patients with